HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of Hepatocyte growth factor activator inhibitor type-1 (HAI-1) in prostate cancer.

AbstractBACKGROUND:
Hepatocyte growth factor activator inhibitor type-1 (HAI-1) inhibits hepatocyte growth factor activator and matriptase. In the present study it was investigated whether the expression of HAI-1 is associated with the progression of prostate cancer.
PATIENTS AND METHODS:
The expression of HAI-1 was evaluated by immunohistochemistry (IHC) of samples from 51 patients with negative prostate biopsies and 75 patients with untreated prostate cancer. Furthermore, the expression of HAI-1 was evaluated in 24 patients with castration-resistant prostate cancer (CRPC), and the relationship between HAI-1 expression and the prostate-specific antigen (PSA) progression-free rate was investigated.
RESULTS:
Expression of HAI-1 by IHC in patients with prostate cancer was significantly higher than in those with negative prostate biopsy. CRPC exhibited significantly lower HAI-1 expression than untreated metastatic prostate cancer. The PSA progression-free rate was worse in patients without HAI-1 expression than in those with positive HAI-1 expression.
CONCLUSION:
It is suggested that HAI-1 may play an important role in the pathogenesis of CRPC.
AuthorsKenji Yasuda, Akira Komiya, Akihiko Watanabe, Akihiro Morii, Takeshi Oya, Osamu Nagakawa, Yasuyoshi Fujiuchi, Hideki Fuse
JournalAnticancer research (Anticancer Res) Vol. 33 Issue 2 Pg. 575-81 (Feb 2013) ISSN: 1791-7530 [Electronic] Greece
PMID23393351 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Androgen Antagonists
  • Biomarkers, Tumor
  • Proteinase Inhibitory Proteins, Secretory
  • SPINT1 protein, human
Topics
  • Aged
  • Androgen Antagonists (therapeutic use)
  • Biomarkers, Tumor (analysis)
  • Disease Progression
  • Disease-Free Survival
  • Drug Resistance, Neoplasm (physiology)
  • Humans
  • Immunohistochemistry
  • Male
  • Neoplasm Grading
  • Neoplasm Staging
  • Prostatic Neoplasms (metabolism, mortality, pathology)
  • Proteinase Inhibitory Proteins, Secretory (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: